Rinvoq LQ 1 mg/mL oral solution Images
Generic Name: upadacitinib
This medication has been identified as Rinvoq LQ 1 mg/mL oral solution. It is supplied by AbbVie Inc.
Rinvoq LQ is used in the treatment of Polyarticular Juvenile Idiopathic Arthritis; Psoriatic Arthritis. Rinvoq LQ 1 mg/mL oral solution is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Rinvoq LQ
- Generic Name
- upadacitinib
- Strength
- 1 mg/mL oral solution
- Availability
- Prescription only
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- AbbVie Inc.
- National Drug Code (NDC)
- 00074-2320
More about Rinvoq LQ (upadacitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy or Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
